In patients with chronic kidney disease (CKD) and COVID-19, activation of the receptor for advanced glycation end products (RAGE) may initiate or exacerbate renal injury, potentially leading to thrombotic complications [25]. The gene discussed is AGER; the disease is chronic kidney disease.